Increased red cell distribution width: A novel predictor of adverse outcome in patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Increased red cell distribution width: A novel predictor of adverse outcome in patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease

Published:2018-03 Issue: Volume:136 Page:1-7
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Epstein Danny,Nasser Roni,Mashiach Tanya,Azzam Zaher S.,Berger Gidon

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference27 articles.

1. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study;Buist;Lancet,2007

2. The Top 10 Causes of Death [Internet];WHO,2017

3. Supported discharge shortens hospital stay in patients hospitalized because of an exacerbation of COPD;Sala;Eur. Respir. J.,2001

4. Study protocol for an evaluation of the effectiveness of “care bundles” as a means of improving hospital care and reducing hospital readmission for patients with chronic obstructive pulmonary disease (COPD);Chalder;BMC Pulm. Med. BMC Pulm. Med.,2016

5. Understanding why patients with COPD get readmitted: a large national study to delineate the medicare population for the readmissions penalty expansion;Shah;Chest,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Utility of Red Blood Cell Distribution Width as a Prognostic Indicator for Deterioration of Patients with Chronic Obstructive Pulmonary Disease Within One Year;International Journal of General Medicine;2024-09

2. Predictive role of red blood cell distribution width and hemoglobin-to-red blood cell distribution width ratio for mortality in patients with COPD: evidence from NHANES 1999–2018;BMC Pulmonary Medicine;2024-08-26

3. Idiopathic pulmonary fibrosis (IPF): Diagnostic routes using novel biomarkers;Biomedical Journal;2024-08

4. Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease;Canadian Respiratory Journal;2024-03-12

5. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients;ERJ Open Research;2024-01